Strong quarterly results: Medplus reported strong quarterly results on May 25, 2023. The company’s revenue grew by 35% year-on-year to Rs 1,260 crore, while its net profit grew by 40% year-on-year to Rs 100 crore.
Financial Results (Q4 FY2023) – QoQ Comparison
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹1266.676 crs | ₹1201.675 crs |  5.41% |
| Net Profit | ₹26.582 crs | ₹13.407 crs | 98.27% |
| EPS | ₹2.24 | ₹1.12 | 100.00% |
Financial Results (Q4 FY2023) – YoY Comparison
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹1266.676 crs | ₹978.955 crs | 29.39% |
| Net Profit | ₹26.582 crs | ₹11.726 crs | 126.69% |
| EPS | ₹2.24 | ₹0.98 | 128.57% |
Positive outlook: Medplus management gave a positive outlook for the future. The company expects to continue to grow its revenue and profit at a healthy pace in the coming quarters.
Investor sentiment: Overall, investor sentiment towards the Indian stock market has been positive in recent weeks. This has led to a rally in many stocks, including Medplus.
It is important to note that the stock market is volatile and share prices can go up and down for a variety of reasons. Investors should always do their own research before investing in any stock.